Valutazione del libro
Maggiori informazioni sul libro
The 45th edition of the leading reference on treatment of infectious diseases and anti-infective drug information. Available in print in pocket size, spiral bound and large library editions. New material and areas of significant change in this 45th edition include: * HCV treatment (Table 14G): Expanded treatment options using the newest direct acting agents (DAA) for interferon-free therapy based on the latest guidelines. * Parasitic diseases (Table 13A): Treatment of parasitic diseases has been comprehensively updated. * Antiretroviral therapy (Table 14): New once daily single tablet regimens have been added. * Antibacterial drug information (Table 9, Table 10): Pharmacology data and adverse effects summary have been extensively updated. * Resistant Bacteria (Tables 1, 5, & 6): Updates reflect the latest data and treatment options, including new agents for treatment of resistant S. aureus. -- Publisher
Acquisto del libro
The Sanford guide to antimicrobial therapy 2015, AA.VV.
- Lingua
- Pubblicato
- 2015
- product-detail.submit-box.info.binding
- (In brossura)
Metodi di pagamento
Qui potrebbe esserci la tua recensione.
- Titolo
- The Sanford guide to antimicrobial therapy 2015
- Lingua
- Inglese
- Autori
- AA.VV.
- Pubblicato
- 2015
- Formato
- In brossura
- Pagine
- 238
- ISBN10
- 1930808844
- ISBN13
- 9781930808843
- Serie
- Valutazione
- 4,45 su 5
- Descrizione
- The 45th edition of the leading reference on treatment of infectious diseases and anti-infective drug information. Available in print in pocket size, spiral bound and large library editions. New material and areas of significant change in this 45th edition include: * HCV treatment (Table 14G): Expanded treatment options using the newest direct acting agents (DAA) for interferon-free therapy based on the latest guidelines. * Parasitic diseases (Table 13A): Treatment of parasitic diseases has been comprehensively updated. * Antiretroviral therapy (Table 14): New once daily single tablet regimens have been added. * Antibacterial drug information (Table 9, Table 10): Pharmacology data and adverse effects summary have been extensively updated. * Resistant Bacteria (Tables 1, 5, & 6): Updates reflect the latest data and treatment options, including new agents for treatment of resistant S. aureus. -- Publisher